Linked Life Data

18624687

Source:http://linkedlifedata.com/resource/pubmed/id/18624687

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-7-15
pubmed:abstractText
Docetaxel has benefited from focused evaluation of its preclinical pharmacology and pharmacokinetics, as well as the evolving areas that are becoming significant to cancer drug development: pharmacogenetics, population pharmacokinetics, and in vivo quantitative pharmacology.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1742-5255
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1007-19
pubmed:dateRevised
2009-11-16
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Lessons learned from development of docetaxel.
pubmed:affiliation
Indiana University, Indianapolis, Indiana, USA.
pubmed:publicationType
Journal Article, Review, Research Support, N.I.H., Extramural